PAICS is the prognostic marker in colorectal cancer patients with stage III

被引：1
|
作者：
Kobayashi, Yusuke [1 ]
Kumamoto, Kensuke [1 ]
Matsumoto, Yoshiko [1 ]
Saito, Motonobu [1 ]
Shimura, Tatsuo [1 ]
Takenoshita, Seiichi [1 ]
机构：
[1] Fukushima Med Univ, Fukushima, Japan
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-3415
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3415
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Enhanced PAICS expression is associated with favorite prognosis in stage III colorectal cancer patients
    Kumamoto, Kensuke
    Kobayashi, Yusuke
    Wada, Yukiko
    Nishiura, Bunpei
    Furuichi, Yumi
    Uemura, Jun
    Asano, Eisuke
    Kishino, Takayoshi
    Okano, Keiichi
    Usuki, Hisashi
    Suzuki, Yasuyuki
    CANCER SCIENCE, 2018, 109 : 1358 - 1358
  • [2] Is Serum Placental Growth Factor a Prognostic Marker for Stage III Colorectal Cancer Patients?
    Gomceli, Ismail
    Tez, Mesut
    Bostanci, Erdal B.
    Ulas, Murat
    Turhan, Nesrin
    Kemik, Ahu S.
    Akoglu, Musa
    HEPATO-GASTROENTEROLOGY, 2012, 59 (117) : 1437 - 1440
  • [3] Serum hepatocyte growth factor as a prognostic marker for stage II or III colorectal cancer patients
    Toiyama, Yuji
    Miki, Chikao
    Inoue, Yasuhiro
    Okugawa, Yoshinaga
    Tanaka, Kouji
    Kusunoki, Masato
    INTERNATIONAL JOURNAL OF CANCER, 2009, 125 (07) : 1657 - 1662
  • [4] Bio-marker prognostic value in stage II-III of colorectal cancer
    Funaioli, Chiara
    Pinto, Carmine
    Ceccarelli, Claudio
    Mutri, Vita
    Gentile, Anna Lisa
    Limpe, Lorena Rojas
    Di Fabio, Francesca
    Longobardi, Ciro
    Martinelli, Giuseppe Nicola
    Martoni, Andrea
    ANNALS OF ONCOLOGY, 2005, 16 : 43 - 43
  • [5] Role of circulating tumor cells as prognostic marker in resected stage III colorectal cancer
    Sotelo, M. J.
    Sastre, J.
    Maestro, M. L.
    Veganzones, S.
    Vieitez, J. M.
    Alonso, V.
    Gravalos, C.
    Escudero, P.
    Vera, R.
    Aranda, E.
    Garcia-Alfonso, P.
    Gallego-Plazas, J.
    Lopez, C.
    Pericay, C.
    Arrivi, A.
    Vicente, P.
    Ballesteros, P.
    Elez, E.
    Lopez-Ladron, A.
    Diaz-Rubio, E.
    ANNALS OF ONCOLOGY, 2015, 26 (03) : 535 - 541
  • [6] Tumor budding as a prognostic marker in stage III colorectal carcinoma
    Choi, H. J.
    Park, K. J.
    Shin, J. S.
    Roh, M. S.
    Kwon, H. C.
    Lee, H. S.
    ISUCRS: PROCEEDINGS OF THE XXI BIENNIAL CONGRESS OF THE INTERNATIONAL SOCIETY OF UNIVERSITY COLON AND RECTAL SURGEONS, 2006, : 61 - +
  • [7] Preoperative Vascular Endothelial Growth Factor Levels as a Prognostic Marker for Stage II or III Colorectal Cancer Patients
    Kemik, Ozgur
    Kemik, Ahu Sarbay
    Sumer, Aziz
    Purisa, Sevim
    Dulger, A. Cumhur
    Begenik, Huseyin
    Hasirci, Ismail
    Tuzun, Sefa
    CANCER GROWTH AND METASTASIS, 2011, 4 : 25 - 32
  • [8] Overexpression of the S100A2 protein as a prognostic marker for patients with stage II and III colorectal cancer
    Masuda, Taiki
    Ishikawa, Toshiaki
    Mogushi, Kaoru
    Okazaki, Satoshi
    Ishiguro, Megumi
    Iida, Satoru
    Mizushima, Hiroshi
    Tanaka, Hiroshi
    Uetake, Hiroyuki
    Sugihara, Kenichi
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2016, 48 (03) : 975 - 982
  • [9] Prognostic Factors Influencing Survival in Stage II and Stage III Colorectal Cancer Patients
    Alkader, Mohammad S.
    Al-Majthoub, Murad Z.
    Al-Qerem, Walid A.
    Alkhader, Doaa M.
    Alhusban, Aseel M.
    Abdulkareem, Muna A.
    Abweny, Bashar
    Hamawi, Alaa T.
    Muslem, Hala F.
    Omesh, Rasha A.
    Al-Adwan, AlAnoud M.
    Al Halaiqah, Hamed A.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (10)
  • [10] HLA-G as a prognostic marker in stage II/III colorectal cancer: not quite there yet
    Gambella, Alessandro
    Scabini, Stefano
    Zoppoli, Gabriele
    De Silvestri, Annalisa
    Pigozzi, Simona
    Paudice, Michele
    Campora, Michela
    Fiocca, Roberto
    Grillo, Federica
    Mastracci, Luca
    HISTOCHEMISTRY AND CELL BIOLOGY, 2022, 158 (06) : 535 - 543
12345